81 related articles for article (PubMed ID: 18189424)
1. Linoleic acid-enriched phospholipids act through peroxisome proliferator-activated receptors alpha to stimulate hepatic apolipoprotein A-I secretion.
Pandey NR; Renwick J; Misquith A; Sokoll K; Sparks DL
Biochemistry; 2008 Feb; 47(6):1579-87. PubMed ID: 18189424
[TBL] [Abstract][Full Text] [Related]
2. Hepatic high-density lipoprotein secretion regulates the mobilization of cell-surface hepatic lipase.
Chatterjee C; Young EK; Pussegoda KA; Twomey EE; Pandey NR; Sparks DL
Biochemistry; 2009 Jun; 48(25):5994-6001. PubMed ID: 19425605
[TBL] [Abstract][Full Text] [Related]
3. Phosphatidylinositol acts through mitogen-activated protein kinase to stimulate hepatic apolipoprotein A-I secretion.
Hopewell S; Pandey NR; Misquith A; Twomey E; Sparks DL
Metabolism; 2008 Dec; 57(12):1677-84. PubMed ID: 19013290
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel selective peroxisome proliferator-activated receptor alpha agonist, 2-methyl-2-(4-{3-[1-(4-methylbenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl]propyl}phenoxy)propanoic acid (LY518674), that produces marked changes in serum lipids and apolipoprotein A-1 expression.
Singh JP; Kauffman R; Bensch W; Wang G; McClelland P; Bean J; Montrose C; Mantlo N; Wagle A
Mol Pharmacol; 2005 Sep; 68(3):763-8. PubMed ID: 15933217
[TBL] [Abstract][Full Text] [Related]
5. Phospholipids as cardiovascular therapeutics.
Pandey NR; Sparks DL
Curr Opin Investig Drugs; 2008 Mar; 9(3):281-5. PubMed ID: 18311664
[TBL] [Abstract][Full Text] [Related]
6. Regulation of human apoA-I by gemfibrozil and fenofibrate through selective peroxisome proliferator-activated receptor alpha modulation.
Duez H; Lefebvre B; Poulain P; Torra IP; Percevault F; Luc G; Peters JM; Gonzalez FJ; Gineste R; Helleboid S; Dzavik V; Fruchart JC; Fiévet C; Lefebvre P; Staels B
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):585-91. PubMed ID: 15618549
[TBL] [Abstract][Full Text] [Related]
7. Reciprocal and coordinate regulation of serum amyloid A versus apolipoprotein A-I and paraoxonase-1 by inflammation in murine hepatocytes.
Han CY; Chiba T; Campbell JS; Fausto N; Chaisson M; Orasanu G; Plutzky J; Chait A
Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1806-13. PubMed ID: 16709944
[TBL] [Abstract][Full Text] [Related]
8. Highly sensitive upregulation of apolipoprotein A-IV by peroxisome proliferator-activated receptor alpha (PPARalpha) agonist in human hepatoma cells.
Nagasawa M; Akasaka Y; Ide T; Hara T; Kobayashi N; Utsumi M; Murakami K
Biochem Pharmacol; 2007 Dec; 74(12):1738-46. PubMed ID: 17904533
[TBL] [Abstract][Full Text] [Related]
9. Pioglitazone stimulates apolipoprotein A-I production without affecting HDL removal in HepG2 cells: involvement of PPAR-alpha.
Qin S; Liu T; Kamanna VS; Kashyap ML
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2428-34. PubMed ID: 17872455
[TBL] [Abstract][Full Text] [Related]
10. Regulation of hepatic peroxisome proliferator-activated receptor alpha expression but not adiponectin by dietary protein in finishing pigs.
Weber TE; Kerr BJ; Spurlock ME
J Anim Physiol Anim Nutr (Berl); 2008 Oct; 92(5):569-77. PubMed ID: 19012601
[TBL] [Abstract][Full Text] [Related]
11. PAR-5359, a well-balanced PPARalpha/gamma dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivo.
Kim MK; Chae YN; Son MH; Kim SH; Kim JK; Moon HS; Park CS; Bae MH; Kim E; Han T; Choi HH; Shin YA; Ahn BN; Lee CH; Lim JI; Shin CY
Eur J Pharmacol; 2008 Oct; 595(1-3):119-25. PubMed ID: 18727927
[TBL] [Abstract][Full Text] [Related]
12. Identification of a functional peroxisome proliferator-activated receptor (PPAR) response element (PPRE) in the human apolipoprotein A-IV gene.
Nagasawa M; Hara T; Kashino A; Akasaka Y; Ide T; Murakami K
Biochem Pharmacol; 2009 Sep; 78(5):523-30. PubMed ID: 19433068
[TBL] [Abstract][Full Text] [Related]
13. An induction in hepatic HDL secretion associated with reduced ATPase expression.
Pandey NR; Renwick J; Rabaa S; Misquith A; Kouri L; Twomey E; Sparks DL
Am J Pathol; 2009 Oct; 175(4):1777-87. PubMed ID: 19717637
[TBL] [Abstract][Full Text] [Related]
14. Role of the nuclear receptors HNF4 alpha, PPAR alpha, and LXRs in the TNF alpha-mediated inhibition of human apolipoprotein A-I gene expression in HepG2 cells.
Mogilenko DA; Dizhe EB; Shavva VS; Lapikov IA; Orlov SV; Perevozchikov AP
Biochemistry; 2009 Dec; 48(50):11950-60. PubMed ID: 19883121
[TBL] [Abstract][Full Text] [Related]
15. Effect of pitavastatin on apolipoprotein A-I production in HepG2 cell.
Maejima T; Yamazaki H; Aoki T; Tamaki T; Sato F; Kitahara M; Saito Y
Biochem Biophys Res Commun; 2004 Nov; 324(2):835-9. PubMed ID: 15474503
[TBL] [Abstract][Full Text] [Related]
16. Improvement of dyslipidemia, insulin sensitivity, and energy balance by a peroxisome proliferator-activated receptor alpha agonist.
Chen X; Matthews J; Zhou L; Pelton P; Liang Y; Xu J; Yang M; Cryan E; Rybczynski P; Demarest K
Metabolism; 2008 Nov; 57(11):1516-25. PubMed ID: 18940388
[TBL] [Abstract][Full Text] [Related]
17. Large-Scale Screening of Natural Products Transactivating Peroxisome Proliferator-Activated Receptor α Identifies 9S-Hydroxy-10E,12Z,15Z-Octadecatrienoic Acid and Cymarin as Potential Compounds Capable of Increasing Apolipoprotein A-I Transcription in Human Liver Cells.
van der Krieken SE; Popeijus HE; Bendik I; Böhlendorf B; Konings MCJM; Tayyeb J; Mensink RP; Plat J
Lipids; 2018 Nov; 53(11-12):1021-1030. PubMed ID: 30706477
[TBL] [Abstract][Full Text] [Related]
18. The effects of short-chain fatty acids on the transcription and secretion of apolipoprotein A-I in human hepatocytes in vitro.
Tayyeb JZ; Popeijus HE; Mensink RP; Konings MCJM; Mulders KHR; Plat J
J Cell Biochem; 2019 Oct; 120(10):17219-17227. PubMed ID: 31106471
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E activates the low-activity form of human phospholipid transfer protein.
Jänis MT; Metso J; Lankinen H; Strandin T; Olkkonen VM; Rye KA; Jauhiainen M; Ehnholm C
Biochem Biophys Res Commun; 2005 May; 331(1):333-40. PubMed ID: 15845396
[TBL] [Abstract][Full Text] [Related]
20. Extracellular nucleotides inhibit insulin receptor signaling, stimulate autophagy and control lipoprotein secretion.
Chatterjee C; Sparks DL
PLoS One; 2012; 7(5):e36916. PubMed ID: 22590634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
